The show is co-hosted by two VCs, Jack Richardson, and Richard Armstrong, exploring the inner workings behind the creation of thriving tech unicorns, showcasing conversations with leading pioneers and visionaries in the global startup arena.
All content for Venture Passport is the property of Richard Armstrong, Jack Richardson and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The show is co-hosted by two VCs, Jack Richardson, and Richard Armstrong, exploring the inner workings behind the creation of thriving tech unicorns, showcasing conversations with leading pioneers and visionaries in the global startup arena.
In this episode, Jack Richardson and Richard Armstrong engage with James Pyre to explore the biotech landscape, delving into his background and the founding of Cambrian. The discussion highlights Cambrian's mission to tackle aging biology and compares biotech to tech investment landscapes. James shares insights into Cambrian's early funding, metabolism research, and drug development efforts. The conversation navigates the complexities of the regulatory environment and data management, emphasizing strategies to accelerate drug development and the future of longevity drugs. The episode wraps up with a quick-fire round of questions with James Pyre, followed by closing remarks.
Venture Passport
The show is co-hosted by two VCs, Jack Richardson, and Richard Armstrong, exploring the inner workings behind the creation of thriving tech unicorns, showcasing conversations with leading pioneers and visionaries in the global startup arena.
